8.140USD-7.61%Mkt Cap: 56.16M USDP/E: —Last update: 2026-06-01
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap56.16M USD
Enterprise Value161.06M USD
Revenue (TTM)33.86M USD
Gross Profit19.65M USD
Net Income (TTM)-358.73M USD
Revenue/Share3.432 USD
Last Price8.140 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees34
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)12.19
PEG—
EV/EBITDA-0.60
EV/Revenue4.76
P/S1.85
P/B-0.30
EPS (TTM)-40.50
EPS (Forward)0.73
52W Range
4.20013% of range34.27
52W High34.27 USD
52W Low4.200 USD
Profitability
Gross Margin64.97%
Oper. Margin-373.49%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
Growth
Revenue Growth72.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M USD
CapEx (TTM)733.00K USD
FCF Margin17.68%
FCF Yield10.66%
Net Debt103.00M USD
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity-0.60
Current Ratio0.08
Quick Ratio0.07
Book Value/Sh-29.5440 USD
Cash/Share0.4780 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:35
Split DateApr 15, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.03M
Float5.19M
Insiders17.56%
Institutions13.11%
Short Interest
Short Ratio1.7d
Short % Float2.85%
Short % Out.2.25%
Shares Short157.97K
Short (prev mo.)158.98K
Technical
SMA 507.197 (+13.1%)
SMA 20013.56 (-40.0%)
Beta1.79
S&P 52W Chg27.70%
Avg Vol (30d)103.89K
Avg Vol (10d)97.21K
Technical Indicators
RSI (14)63.9
MACD-0.1760
MACD Signal-0.3035
MACD Hist.+0.1275
BB Upper10.97 USD
BB Middle7.476 USD
BB Lower3.985 USD
BB Width93.38%
ATR (14)0.9889 USD
Vol Ratio (20d)3.05x